142 related articles for article (PubMed ID: 2829418)
1. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
[TBL] [Abstract][Full Text] [Related]
2. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
Murphy D; Bishop A; Rindi G; Murphy MN; Stamp GW; Hanson J; Polak JM; Hogan B
Am J Pathol; 1987 Dec; 129(3):552-66. PubMed ID: 2827490
[TBL] [Abstract][Full Text] [Related]
3. Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene.
Stefaneanu L; Rindi G; Horvath E; Murphy D; Polak JM; Kovacs K
Endocrinology; 1992 Apr; 130(4):1789-95. PubMed ID: 1312426
[TBL] [Abstract][Full Text] [Related]
4. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
[TBL] [Abstract][Full Text] [Related]
5. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
Asa SL; Lee YC; Drucker DJ
Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse models and peptide producing endocrine tumours: morpho-functional aspects.
Rindi G; Solcia E; Polak JM
Experientia Suppl; 1989; 56():210-9. PubMed ID: 2522889
[TBL] [Abstract][Full Text] [Related]
7. Morphological study of pituitary tumorigenesis in transgenic mice induced by hybrid oncogene of the thyrotropin beta-subunit and the simian virus 40 large T-antigen.
Kon Y; Miyoshi I; Maki K; Yamashita T; Aoyama S; Watanabe T; Hayashizaki Y; Kasai N
Histol Histopathol; 1997 Oct; 12(4):981-90. PubMed ID: 9302559
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
9. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
10. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.
Hanahan D
Nature; 1985 May 9-15; 315(6015):115-22. PubMed ID: 2986015
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.
Ornitz DM; Hammer RE; Messing A; Palmiter RD; Brinster RL
Science; 1987 Oct; 238(4824):188-93. PubMed ID: 2821617
[TBL] [Abstract][Full Text] [Related]
12. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice.
Windle JJ; Weiner RI; Mellon PL
Mol Endocrinol; 1990 Apr; 4(4):597-603. PubMed ID: 1704103
[TBL] [Abstract][Full Text] [Related]
13. Targeted pituitary tumorigenesis using the human thyrotropin beta-subunit chain promoter in transgenic mice.
Maki K; Miyoshi I; Kon Y; Yamashita T; Sasaki N; Aoyama S; Takahashi E; Namioka S; Hayashizaki Y; Kasai N
Mol Cell Endocrinol; 1994 Nov; 105(2):147-54. PubMed ID: 7859921
[TBL] [Abstract][Full Text] [Related]
14. Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes.
Efrat S; Baekkeskov S; Lane D; Hanahan D
EMBO J; 1987 Sep; 6(9):2699-704. PubMed ID: 2824189
[TBL] [Abstract][Full Text] [Related]
15. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression.
Rindi G; Grant SG; Yiangou Y; Ghatei MA; Bloom SR; Bautch VL; Solcia E; Polak JM
Am J Pathol; 1990 Jun; 136(6):1349-63. PubMed ID: 2162628
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
[TBL] [Abstract][Full Text] [Related]
17. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
[TBL] [Abstract][Full Text] [Related]
18. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
Bossé P; Bernex F; De Sepulveda P; Salaün P; Panthier JJ
Oncogene; 1997 Jun; 14(22):2661-70. PubMed ID: 9178764
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
20. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.
Levine DS; Sanchez CA; Rabinovitch PS; Reid BJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6427-31. PubMed ID: 1650467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
